{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:08:19Z","timestamp":1791875299434,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"PhaseRx, Inc."}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ymthe.2017.12.024","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T22:11:51Z","timestamp":1515017511000},"page":"801-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency"],"prefix":"10.1016","volume":"26","author":[{"given":"Mary G.","family":"Prieve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrot","family":"Harvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean D.","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen G.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri L.","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber E.","family":"Paschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Waldheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Galperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Rene","family":"Ella-Menye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.12.024_bib1","series-title":"GeneReviews(R)","article-title":"Ornithine transcarbamylase deficiency","author":"Lichter-Konecki","year":"1993"},{"key":"10.1016\/j.ymthe.2017.12.024_bib2","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.12.024_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/genes8020065","article-title":"Advances in non-viral DNA vectors for gene therapy","volume":"8","author":"Hardee","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2017.12.024_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.12.024_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2017.12.024_bib7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/CVI.05107-11","article-title":"Adeno-associated virus antibody profiles in newborns, children, and adolescents","volume":"18","author":"Calcedo","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ymthe.2017.12.024_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.12.024_bib9","first-page":"1","article-title":"Viral vectors: a look back and ahead on gene transfer technology","volume":"36","author":"Vannucci","year":"2013","journal-title":"New Microbiol."},{"key":"10.1016\/j.ymthe.2017.12.024_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/wrna.1288","article-title":"Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond","volume":"6","author":"Vallazza","year":"2015","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.ymthe.2017.12.024_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.2015.973859","article-title":"mRNA transcript therapy","volume":"14","author":"Weissman","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2017.12.024_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2011.07.004","article-title":"An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions","volume":"104","author":"El-Gharbawy","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.12.024_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2009.01.019","article-title":"The many pathways of RNA degradation","volume":"136","author":"Houseley","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.12.024_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.ymthe.2017.12.024_bib15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In\u00a0vitro and in\u00a0vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2017.12.024_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2008.10.004","article-title":"Development of a novel endosomolytic diblock copolymer for siRNA delivery","volume":"133","author":"Convertine","year":"2009","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.12.024_bib17","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/bm100652w","article-title":"pH-responsive polymeric micelle carriers for siRNA drugs","volume":"11","author":"Convertine","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ymthe.2017.12.024_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/bc300486k","article-title":"Neutral polymeric micelles for RNA delivery","volume":"24","author":"Lundy","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ymthe.2017.12.024_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/9780470122860.ch3","article-title":"The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins","volume":"41","author":"Ashwell","year":"1974","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.ymthe.2017.12.024_bib20","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.78.6.3348","article-title":"Identification and quantification of the rat hepatocyte asialoglycoprotein receptor","volume":"78","author":"Schwartz","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.12.024_bib21","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1073\/pnas.0703778104","article-title":"Dynamic PolyConjugates for targeted in\u00a0vivo delivery of siRNA to hepatocytes","volume":"104","author":"Rozema","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.12.024_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2015.04.012","article-title":"Protease-triggered siRNA delivery vehicles","volume":"209","author":"Rozema","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.12.024_bib23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/mt.2011.56","article-title":"An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA","volume":"19","author":"Adami","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib24","doi-asserted-by":"crossref","first-page":"382184","DOI":"10.1155\/2013\/382184","article-title":"Efficient hepatic delivery of drugs: novel strategies and their significance","volume":"2013","author":"Mishra","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ymthe.2017.12.024_bib25","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2017.12.024_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/nat.2011.0298","article-title":"Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif","volume":"21","author":"Jurk","year":"2011","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.6623083","article-title":"Biogenesis of ornithine transcarbamylase in spfash mutant mice: two cytoplasmic precursors, one mitochondrial enzyme","volume":"222","author":"Rosenberg","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.12.024_bib28","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1073\/pnas.86.11.4142","article-title":"The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing","volume":"86","author":"Hodges","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.12.024_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/mt.2011.32","article-title":"Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery","volume":"19","author":"Cunningham","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00209398","article-title":"Demonstration of the spf-ash mutation in Spanish patients with ornithine transcarbamylase deficiency of moderate severity","volume":"95","author":"Garc\u00eda-P\u00e9rez","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2017.12.024_bib31","first-page":"e28387","article-title":"Why is start codon selection so precise in eukaryotes?","volume":"2","author":"Asano","year":"2014","journal-title":"Translation (Austin)"},{"key":"10.1016\/j.ymthe.2017.12.024_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573396312666160627124242","article-title":"Long term complications in pediatric liver transplant recipients: what every pediatrician should know","volume":"12","author":"Youssef","year":"2016","journal-title":"Curr. Pediatr. Rev."},{"key":"10.1016\/j.ymthe.2017.12.024_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2011.10.020","article-title":"Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome","volume":"105","author":"Wang","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.12.024_bib34","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mt.2009.88","article-title":"AAV2\/8-mediated correction of OTC deficiency is robust in adult but not neonatal Spf(ash) mice","volume":"17","author":"Cunningham","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2017.12.024_bib36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/gt.2013.51","article-title":"AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia","volume":"20","author":"Cunningham","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/hum.2017.150","article-title":"Unraveling the complex story of immune responses to AAV vectors trial after trial","volume":"28","author":"Vandamme","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1089\/hum.2017.022","article-title":"Regulatory and exhausted T\u00a0cell responses to AAV capsid","volume":"28","author":"Gernoux","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.12.024_bib40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.12.024_bib41","doi-asserted-by":"crossref","first-page":"e56220","DOI":"10.1371\/journal.pone.0056220","article-title":"In\u00a0vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle","volume":"8","author":"Uchida","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2017.12.024_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2015.01.017","article-title":"Treatment of neurological disorders by introducing mRNA in\u00a0vivo using polyplex nanomicelles","volume":"201","author":"Baba","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.12.024_bib43","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1016\/j.biomaterials.2012.06.020","article-title":"Multifunctional triblock copolymers for intracellular messenger RNA delivery","volume":"33","author":"Cheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2017.12.024_bib44","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in\u00a0vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2017.12.024_bib45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.12.024_bib46","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/adma.201505822","article-title":"Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in\u00a0vivo mRNA delivery","volume":"28","author":"Fenton","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2017.12.024_bib47","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1038\/ncomms14630","article-title":"Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge","volume":"8","author":"Pardi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2017.12.024_bib48","first-page":"e201707678","article-title":"mRNA mediates passive vaccination against infectious agents, toxins, and tumors","author":"Thran","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2017.12.024_bib49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/nat.2012.0389","article-title":"Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in\u00a0vivo","volume":"22","author":"Wong","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S1516-31801999000600006","article-title":"Inborn errors of metabolism: a clinical overview","volume":"117","author":"Martins","year":"1999","journal-title":"Sao Paulo Med. J."},{"key":"10.1016\/j.ymthe.2017.12.024_bib51","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta1110","article-title":"Newborn screening for inborn errors of metabolism: a systematic review","volume":"1","author":"Seymour","year":"1997","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ymthe.2017.12.024_bib52","unstructured":"Mew, N. (2017). Ornithine transcarbamylase deficiency. https:\/\/rarediseases.org\/rare-diseases\/ornithine-transcarbamylase-deficiency\/."},{"key":"10.1016\/j.ymthe.2017.12.024_bib53","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1021\/ma9804951","article-title":"Living free-radical polymerization by reversible addition\u2212fragmentation chain transfer: the RAFT process","volume":"31","author":"Chiefari","year":"1998","journal-title":"Macromolecules"},{"key":"10.1016\/j.ymthe.2017.12.024_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.12.024_bib55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2017.12.024_bib56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/104303401750214267","article-title":"Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors","volume":"12","author":"Ye","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.024_bib57","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:53:07Z","timestamp":1761501187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1525001618300066"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.12.024","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}